Nutriband opened lower at $5.90, compared with its previous close of $5.94. In the last trading session, the stock traded between $5.84 and $6.05. It showed a sideways intraday trend.
Return calculator
Time Period
An investment of $100 made 5 years ago in Nutriband is now worth
$ 115.98
Giving a profit of
$ 15.98 (15.98%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
No analyst rating data available.
Markets Today
Today's Change
+$0.01 (+0.08%)
Day High
$6.05
Day Low
$5.84
Day Open
$5.90
Prev Close
$5.94
Volume
20,629
1W Return
-1.18%
1M Return
-0.25%
3M Return
85.03%
6M Return
62.88%
1Y Return
-2.38%
Fundamentals
Market Cap ($ Mn)
72
PE Ratio
-
PB Ratio
9.15
PEG Ratio
-
ROE
-120.16%
ROCE
-118.16%
EPS (TTM)
$-0.07
Investment Returns
1 Week
-1.18%
1 Month
-0.25%
3 Months
85.03%
6 Months
62.88%
9 Months
37.94%
Financials
Quarterly
All values in $ Mn
0.7
Apr 25
0.6
Jul 25
0.3
Oct 25
0.4
Jan 26
0.4
Apr 26
0.4
Jul 26
Updates
8Oct
Nutriband files US patent to extend AVERSA tech protection
Filed a U.S. patent application for improved aversive formulations and coating methods. Potential extension of patent protection for AVERSA™ products until 2046 if granted. Technology currently protected by patents issued in 46 countries globally. Aims to prevent abuse and diversion of opioids and stimulants via transdermal patches.
1mo ago
2Oct
Nutriband marks five years on Nasdaq as 2021 warrants expire
Nutriband marked its fifth Nasdaq anniversary with warrants from the 2021 offering expiring on September 30, 2026. Lead product AVERSA Fentanyl advanced to commercial scale-up, with patent protection now covering 46 countries. Revenue growth was driven by subsidiary Pocono Pharma, reaching $645,796 in Q3FY24, up 51% YoY. Company states it has no debt following the expiration of warrants and prior equity conversions.
1mo ago
5Sep
Nutriband Q2 Results: EPS loss narrows to $(0.07), sales fall 29%
Nutriband’s quarterly per-share loss narrowed 96.7% to $(0.07) from $(2.12) YoY. Sales fell 29.71% to $437.514 thousand, down from $622.452 thousand. Revenue decline contrasts sharply with significant improvement in EPS loss.
2mo ago
12Jun
Nutriband narrows Q1 loss to $(0.10) per share as sales fall
Nutriband reduced its Q1 net loss per share to $(0.10), improving from $(0.12) YoY, while sales dropped 35.06% to $433.399 thousand. The company faces pressure on top-line growth despite narrowing losses.
